Product Information
LEVETIRACETAM 250 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0584 per EA under NDC 50228047012. Its NADAC has been published 193 times since Dec 14, 2022.
FDA first approved this application on Jun 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228047012
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA215069FDA Approved
6/11/2021
TE Code
AB
On Market Since
5/27/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 250 MG TABLET has been published 193 times since Dec 14, 2022, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0584 per EA |
|---|---|
| All-time high | $0.0740 (Dec 13, 2023) |
| All-time low | $0.0454 (Nov 20, 2024) |
| 52-week high | $0.0629 |
| 52-week low | $0.0562 |
| Median price | $0.0613 |
| Average price | $0.0617 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 193 |
| Tracking since | Dec 14, 2022 |
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0584 per EA (NDC 50228047012), effective Aug 19, 2026.
How has the price of LEVETIRACETAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 18.2%. It has been tracked across 193 weekly CMS publications since Dec 14, 2022.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?
Since Dec 14, 2022, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0454 (Nov 20, 2024) to a high of $0.0740 (Dec 13, 2023), with a median of $0.0613 per EA.
Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 15% below LEVETIRACETAM 250 MG TABLET.
Who manufactures LEVETIRACETAM 250 MG TABLET?
LEVETIRACETAM 250 MG TABLET (NDC 50228047012) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.